Company · ELV
Elevance Health, Inc.
Nasdaq's symbol directory lists ELV on the New York Stock Exchange as “Elevance Health, Inc. Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($1.4M); insiders sold on 5 occasions ($6.1M); 3 planned-sale notices; 8 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Kaye Mark, EVP & CFO sold $4.7M
- BOUDREAUX GAIL, President and CEO bought $1.0M
- Penczek Ronald W, CAO & Controller sold $766K
- LAVU RATNAKAR, EVP & Chief Digital Info Ofr sold $572K
- PERU RAMIRO G bought $366K
- Dixon Robert L JR sold $61K
Every trade (7)
- SELLLAVU RATNAKAR, EVP & Chief Digital Info Ofr sold $572K
- SELLKaye Mark, EVP & CFO sold $4.7M
- BUYBOUDREAUX GAIL, President and CEO bought $1.0M
- BUYPERU RAMIRO G bought $366K
- SELLPenczek Ronald W, CAO & Controller sold $149K
- SELLDixon Robert L JR sold $61K
- SELLPenczek Ronald W, CAO & Controller sold $617K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- RATNAKAR LAVU $572K
- MARK B KAYE $4.7M
- CLARK R KERRY $630K
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Alan Armstrong (R-OK): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Markwayne Mullin (R-OK): Purchase $15,001 - $50,000
Executive branch · OGE Form 278-T
Reported by the President
3 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Purchase: ELEVANCE HEALTH INC $1,001 – $15,000
- Purchase: ELEVANCE HEALTH INC $15,001 – $50,000
- Purchase: ELEVANCE HEALTH INC $50,001 – $100,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Regulation FD disclosure Nov 10, 2026
- Results of operations and financial condition Oct 21, 2026
- Regulation FD disclosure Sep 10, 2026
- Results of operations and financial condition Jul 15, 2026
Lobbying · Senate LDA reports
Lobbying filed
13 quarterly lobbying reports for 2026 naming Elevance Health, Inc. as the client: 3 filed by the company itself, 10 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- The company itself $2.3M
- TIBER CREEK GROUP $90K
- MEHLMAN CONSULTING, INC. $90K
- TARPLIN, DOWNS & YOUNG, LLC $80K
- CAPITOL HILL CONSULTING GROUP $60K
- ALB SOLUTIONS $60K
- The company itself $2.1M
- The company itself $1.7M
- MEHLMAN CONSULTING, INC. $90K
- TIBER CREEK GROUP $90K
- TARPLIN, DOWNS & YOUNG, LLC $80K
- ALB SOLUTIONS $60K
- CAPITOL HILL CONSULTING GROUP $60K
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.